1. Home
  2. GALT vs DOYU Comparison

GALT vs DOYU Comparison

Compare GALT & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • DOYU
  • Stock Information
  • Founded
  • GALT 2000
  • DOYU 2014
  • Country
  • GALT United States
  • DOYU China
  • Employees
  • GALT N/A
  • DOYU N/A
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • DOYU Computer Software: Programming Data Processing
  • Sector
  • GALT Health Care
  • DOYU Technology
  • Exchange
  • GALT Nasdaq
  • DOYU Nasdaq
  • Market Cap
  • GALT 232.3M
  • DOYU 203.1M
  • IPO Year
  • GALT N/A
  • DOYU 2019
  • Fundamental
  • Price
  • GALT $5.49
  • DOYU $7.09
  • Analyst Decision
  • GALT Strong Buy
  • DOYU Hold
  • Analyst Count
  • GALT 3
  • DOYU 1
  • Target Price
  • GALT $6.00
  • DOYU $7.00
  • AVG Volume (30 Days)
  • GALT 443.8K
  • DOYU 39.8K
  • Earning Date
  • GALT 11-14-2025
  • DOYU 11-20-2025
  • Dividend Yield
  • GALT N/A
  • DOYU 139.49%
  • EPS Growth
  • GALT N/A
  • DOYU N/A
  • EPS
  • GALT N/A
  • DOYU N/A
  • Revenue
  • GALT N/A
  • DOYU $566,928,371.00
  • Revenue This Year
  • GALT N/A
  • DOYU N/A
  • Revenue Next Year
  • GALT N/A
  • DOYU N/A
  • P/E Ratio
  • GALT N/A
  • DOYU N/A
  • Revenue Growth
  • GALT N/A
  • DOYU N/A
  • 52 Week Low
  • GALT $0.73
  • DOYU $5.68
  • 52 Week High
  • GALT $6.55
  • DOYU $16.99
  • Technical
  • Relative Strength Index (RSI)
  • GALT 51.59
  • DOYU 55.43
  • Support Level
  • GALT $5.23
  • DOYU $6.55
  • Resistance Level
  • GALT $6.32
  • DOYU $7.10
  • Average True Range (ATR)
  • GALT 0.55
  • DOYU 0.30
  • MACD
  • GALT -0.05
  • DOYU 0.04
  • Stochastic Oscillator
  • GALT 36.22
  • DOYU 94.41

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About DOYU DouYu International Holdings Limited ADS

DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.

Share on Social Networks: